Novo Nordisk: Tackling China's Obesity Challenge Through Chronic Disease Management and Innovative Drug DevelopmentThe rising prevalence of obesity in China poses a significant challenge. Obesity has become a serious chronic disease, substantially increasing the risk of other chronic conditions such as diabetes and cardiovascular diseases...